MoneyWorks4Me

Hester Biosciences - Quaterly Results

10 May 2024 Evaluate
The Revenue for the quarter ended  March 2024 of Rs. 728.72 millions grew by 20.06 % from Rs. 606.96 millions.Net profit stood at Rs. 74.31  millions  compared to Rs. 62.63 millions in the corresponding previous quarter,high by 18.65%.Operating profit for the quarter ended March 2024 rose to 136.18 millions as compared to 118.69 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 728.72 606.96 20.06 2851.55 2540.00 12.27 2851.55 2540.00 12.27
Other Income 12.03 9.50 26.63 42.62 53.23 -19.93 42.62 53.23 -19.93
PBIDT 136.18 118.69 14.74 516.03 602.09 -14.29 516.03 602.09 -14.29
Interest 13.10 3.48 276.44 50.93 64.97 -21.61 50.93 64.97 -21.61
PBDT 123.08 115.21 6.83 465.10 537.12 -13.41 465.10 537.12 -13.41
Depreciation 20.83 26.21 -20.53 97.78 97.88 -0.10 97.78 97.88 -0.10
PBT 102.25 89.00 14.89 367.32 439.24 -16.37 367.32 439.24 -16.37
TAX 27.94 26.37 5.95 95.73 115.82 -17.35 95.73 115.82 -17.35
Deferred Tax -4.82 3.47 -238.90 -0.62 8.55 -107.25 -0.62 8.55 -107.25
PAT 74.31 62.63 18.65 271.59 323.42 -16.03 271.59 323.42 -16.03
Equity 85.07 85.07 0.00 85.07 85.07 0.00 85.07 85.07 0.00
PBIDTM(%) 18.69 19.55 -4.43 18.10 23.70 -23.66 18.10 23.70 -23.66
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1213.00
Cipla 1373.35
Lupin 2093.60
Zydus Lifesciences 1161.25
View more..